BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 4, 2002
View Archived Issues
Muscle stem cells may be useful in the regeneration of dystrophic muscle
Read More
MedImmune to develop antibodies and vaccines against hMPV
Read More
Amsterdam Molecular Therapeutics licenses rights to IL-10 for ex vivo gene therapy
Read More
AERx iDMS enters phase III program
Read More
Pediatric indication approved for Zenapax
Read More
Pharmacodynamic and pharmacokinetic profile of fesoterodine
Read More
Potential new therapeutic for functional dyspepsia presented at medicinal chemistry meeting
Read More
Spanish investigators discover potent and selective inhibitor of the endocannabinoid transporter
Read More
SSR-69071 selected for development as an HLE inhibitor for respiratory diseases
Read More
Bladder-selective potassium channel openers described by Abbott and ICAgen
Read More
Orally active LH receptor agonist with efficacy in inducing ovulation in mice
Read More
Non-nephrotoxic AMPA antagonist S-34730-1 with potential in neurodegenerative diseases
Read More
Ezetimibe + statins consistently better than statin therapy alone
Read More
Keryx Biopharmaceuticals focuses resources on KRX-101 and KRX-123
Read More
Improved renal function associated with TA-0201 + enalapril in dogs with CHF
Read More
Tadalafil receives positive recommendation in Australia
Read More
FDA issues approvable letter for aripiprazole
Read More
Once-weekly risedronate approved in Sweden
Read More
Bayer and Boehringer Ingelheim sign letter of intent for marketing of telmisartan
Read More
A.P. Pharma withdraws APF-112 phase II protocol
Read More
Potential of fidarestat in diabetic retinopathy emerges from preclinical studies
Read More
Compounds with the ability to inhibit phosphorylation of STAT6 claimed by Pola
Read More
Merck & Co. discloses HIV integrase inhibitors
Read More
Compounds for glaucoma and ocular hypertension with improved profile over natural prostaglandins
Read More
Novel radiopharmaceuticals for imaging sites of infection and/or inflammation
Read More
Antibacterial carbapenems described by Sumitomo
Read More